BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Saizen somatropin: Postmarketing study started

Merck's Merck Serono S.A. unit began the international postmarketing ECOS trial to evaluate patient adherence to Saizen delivered via its electronic auto-injector easypod over 5 years...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >